榆黄蘑对小鼠血乳酸,血尿素,乳酸脱氢酶影响的实验研究

以小鼠为实验材料，研究榆黄蘑发酵液对血乳酸、乳酸脱氢酶（ＬＤＨ）、血尿素（ＢＵＮ）的影响。结果表明，与对照组比较，服用榆黄蘑发酵液２５ｄ的小鼠剧烈运动停止后５０ｍｉｎ，血乳酸含量降低３２％（Ｐ＜０．０５）；乳酸在血液中的清除速率提高１９．５％（Ｐ＜０．０１）；血清ＬＤＨ活性提高１１．６％（Ｐ＜０．０５）。ＢＵＮ增量降低６５％（Ｐ＜０．０５）。实验结果提示榆黄蘑有较好的抗疲劳作用。     

4—甲基—6—羟基—2—吡啶酮衍生物的互变异构研究

合成和精制了五个４－甲基－６－羟基－２－吡啶酮衍生物，用核磁共振波谱和 红外光谱研究了它们在氘代二甲基亚砜溶液中的烯醇式、双酮式互变异构平 衡。热力学参数的计算表明，从烯醇式到双酮式构型的转变是一个吸热过程。 当氮原子上带有体积较大的取代基时，在相同的条件下，化合物更容易以双 酮式构型存在。     

Zn2SnO4复合氧化物气敏特性研究

采用烧结法合成Zn_2SnO_4复合氧化物,具有反尖晶石结构的弱N型半导体材料,其气敏性能引人注目,尤其是对乙醇具有较高的灵敏度和选择性.当掺入少量氧化物杂质,可以看到灵敏度和最佳工作温度都有所改善,其中以稀土氧化物效果为最佳.     

由氨基酸序列预测蛋白质二级结构的进一步研究

本文在工作[1][2]的基础上进一步研究了蛋白质二级结构的经验预测,着重讨论了如何制定预测规则的问题,并将预测工作计算机化.在蛋白质资料库中随机选取了21个蛋白质(3296残基)进行预测,正确率对α螺旋和β折迭分别为84.4%和81.9%.     

结晶紫—锗钨酸—PVA体系显色反应的研究

本文研究了结晶紫-锗钨酸-PVA体系的显色反应。显色反应的条件是:[H_2SO_4]=0.13mol/L,(结晶紫)=1.2×10~(-4)mol/L,(聚乙烯醇)=0.32％。结晶紫-锗钨酸缔合物的最大吸收在545nm处,表观摩尔吸光系数为1.1×10~5L·mol~(-1)·cm~(-1),锗钨酸在0-3.2×10~(-6)mol/L范围内服从比耳定律,发色完全后1小时内吸光度稳定。由热重量法及摩尔比法测得离子缔合物中结晶紫离子:GeW_(12)O_(40)~(4-)=3:1。     

“铅树”生成条件的研究

提出了生成“铅树”反应成功的关键是硅酸凝胶的坚固性,找到了较好的硅酸凝胶的制备条件,使该氧化还原平衡移动的反应成功率提高了９０ ％ 以上．     

初探西洋参须根皂甙提取的新方法

在西洋参须根粉浸泡液中添加适量酵母菌等,恒温发酵。边发酵,边浸提。结果表明：此方法与目前普遍采用的化学方法一样,能提取出西洋参须根中的有效成份皂甙,且发酵液含有１６种氨基酸。     

PKCα反义RNA对乳腺癌细胞增殖及cyclinD1和CDK4表达的影响

ＰＫＣ,ｃｙｃｌｉｎ和ＣＤＫ基因直接参于调控细胞的增殖与分化,因此它们在细胞癌变中的作用已成为重要的研究课题。利用反义ＲＮＡ技术抑制ＰＫＣａ基因的表达,然后观察分析了乳腺癌细胞增殖的变化以及对ｃｙｃｌｉｎＤ１和ＣＤＫ４基因表达的影响。     

Dexamethasone enhances CTLA-4 expression during T cell activation

T cell activation is enhanced by the costimulatory interaction of B7 on antigen-presenting cells and CD28 on T cells, resulting in long-term T cell proliferation, differentiation and production of large amounts of cytokines, such as interleukin (IL)-2. CTLA-4 is a co-stimulation receptor that shares 31% homology with CD28 and binds B7 family members with higher affinity. CTLA-4 is transiently expressed intracellularly and on the cell surface following activation of T cells. We have studied the kinetics of CTLA-4 expression and the effects of dexamethasone on CTLA-4 expression during T cell activation in cultures of mouse spleen cells stimulated by a mixture of immobilized anti-CD3 and anti-CD28 monoclonal antibodies (anti-CD3/CD28 mAb) or concanavalin A (ConA). CTLA-4 expression peaked on day 2 and returned to background levels after 7 days. Dexamethasone was found to potentiate CTLA-4 expression in a dose-dependent manner with an EC₅₀ effective concentration 50%) of about 10⁻⁸ M. In contrast, other immunosuppressive agents, such as rapamycin or cyclosporin A had no or an inhibitory effect on CTLA-4 expression, respectively. Dexamethasone also stimulated CD28 expression, but inhibited IL-2R expression during anti-CD3/CD28 mAb-induced mouse splenic T cell activation. Western blot analyses of lysates of activated mouse T cells showed that dexamethasone increased CTLA-4 protein levels twofold during anti-CD3/CD28 mAb-induced activation. Dexamethasone also enhanced CTLA-4 messenger RNA twofold as quantified by ribonuclease protection assay. The effects of dexamethasone on CTLA-4 expression were glucocorticoid-specific and completely inhibited by the glucocorticoid receptor antagonist mifepristone (RU486), indicating that the effect of dexamethasone on CTLA-4 expression is mediated through the glucocorticoid receptor. In conclusion, the immunosuppressive agent dexamethasone actually stimulates CTLA-4 expression, which is involved in downregulation of T cell activation. Received 19 May 1999; received after revision 13 July 1999; accepted 13 July 1999